Joseph A. Picoraro, MD

Board Certifications: 
Pediatric Gastroenterology, Pediatrics
Accepting New Patients
Treats Children
Profile Hero

Overview

Areas of Expertise / Conditions Treated

Inflammatory Bowel Disease, Eosinophilic Esophagitis, Medical Quality

Academic Appointments

  • Assistant Professor of Pediatrics

Dr. Joseph Picoraro is a pediatric gastroenterologist who strives to provide comprehensive care for each child in the context of his or her family. He specializes in inflammatory bowel disease (IBD), intestinal immunological conditions, eosinophilic esophagitis and congenital diarrhea. He leads the pediatric IBD center at Columbia University Irving Medical Center and is the Director of Pediatric GI Inpatient Services at NewYork-Presbyterian Morgan Stanley Children's Hospital. He serves on the Greater New York Chapter Medical Advisory and Government and Industry Affairs Committees of the Crohn’s and Colitis Foundation and the Clinical Care and Quality Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

Dr. Picoraro completed medical school training (MD) at University of Pennsylvania Perelman School of Medicine, internship and residency training in general pediatrics at the Children's Hospital of Philadelphia and pediatric gastroenterology, hepatology and nutrition fellowship training at NewYork-Presbyterian Morgan Stanley Children’s Hospital and Columbia University Irving Medical Center.

Dr. Picoraro is driven to foster a medical system in which children and families are provided targeted treatments while incorporating inclusive decision-making. His research focuses on improving the comprehensive and tailored care of children with gastrointestinal diseases, with a focus on Crohn’s disease and ulcerative colitis. 

Hospital Affiliations

  • NewYork-Presbyterian/Morgan Stanley Children's Hospital
  • NewYork-Presbyterian/Weill Cornell

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-5903

Location(s)

CUMC/NewYork-Presbyterian Morgan Stanley Children's Hospital
3959 Broadway
New York, NY 10032
Primary
ColumbiaDoctors West 86th Street
21 West 86th Street
New York, NY 10024

Insurance Accepted

For billing questions, please call (212) 304-7250.

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Access (Exchange)
  • EPO
  • Gatekeeper (Exchange)
  • HMO
  • Medicare Managed Care
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • MVP Health Care-Hudson Health Plan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

TRICARE

  • TRICARE

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • MD, University of Pennsylvania School of Medicine
  • Internship: Children's Hospital of Philadelphia
  • Residency: Children's Hospital of Philadelphia
  • Fellowship: Morgan Stanley Children's Hospital of NewYork-Presbyterian

Board Certifications

  • Pediatric Gastroenterology
  • Pediatrics

Research

Pediatric medicine extends the entire lifespan and discovery in children informs our understanding of fundamental mechanisms of human disease. Dr. Picoraro is driven to accelerate clinical innovations, utilizing insights from molecular underpinnings of disease.

Dr. Picoraro’s research focuses on the precision of diagnosis and treatment of children with Crohn’s disease and ulcerative colitis, incorporating systems improvement, care delivery optimization and processes of inclusive decision-making.

Research Interests

  • Inflammatory bowel disease (Crohn’s disease and ulcerative colitis)
  • Medical systems improvement
  • Clinical decision-making

Clinical Trials

A PHASE 2, RANDOMIZED, DOUBLE-BLIND, DOSE-RANGING STUDY TO DETERMINE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF VEDOLIZUMAB IV IN PEDIATRIC SUBJECTS WITH ULCERATIVE COLITIS OR CROHN''S DISEASE

NCT03138655; Project Dates: Jan 11 2018 to Jan 11 2023

A PHASE 2B, EXTENSION STUDY TO DETERMINE THE LONG-TERM SAFETY OF VEDOLIZUMAB IV IN PEDIATRIC SUBJECTS WITH ULCERATIVE COLITIS OR CROHN''S DISEASE LONG-TERM SAFETY WITH VEDOLIZUMAB IV IN PEDIATRIC SUBJECTS WITH ULCERATIVE COLITIS OR CROHN''S DISEASE

NCT03196427; Project Dates: Jan 11 2018 to Jan 11 2023

Grants

A PHASE 3 RANDOMIZED OPEN LABEL STUDY TO ASSESS THE EFFICACY SAFETY AND PHARMACOKINETICS OF GOLIMUMAB TREATMENT A HUMAN ANTI-TNFA MONOCLONAL ANTIBODY ADMINISTERED SUBCUTANEOUSLY IN PEDIATRIC PARTICPANTS W MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLOTIS. (P&S Industry Clinical Trial)

Apr 18 2019 - Apr 18 2024

A PHASE 2, RANDOMIZED, DOUBLE-BLIND, DOSE-RANGING STUDY TO DETERMINE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF VEDOLIZUMAB IV IN PEDIATRIC SUBJECTS WITH ULCERATIVE COLITIS OR CROHN''S DISEASE (P&S Industry Clinical Trial)

Jan 11 2018 - Jan 11 2023

A PHASE 2B, EXTENSION STUDY TO DETERMINE THE LONG-TERM SAFETY OF VEDOLIZUMAB IV IN PEDIATRIC SUBJECTS WITH ULCERATIVE COLITIS OR CROHN''S DISEASE LONG-TERM SAFETY WITH VEDOLIZUMAB IV IN PEDIATRIC SUBJECTS WITH ULCERATIVE COLITIS OR CROHN''S DISEASE (P&S Industry Clinical Trial)

Jan 11 2018 - Jan 11 2023

AN OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE PHARMACOKINETICS OF SINGLE AND MULTIPLE INTRAVENOUS DOSES OF PANTOPRAZOLE IN TWO AGE COHORTS OF HOSPITALIZED PEDIATRIC SUBJECTS 1 TO 16 YEARS OF AGE WHO ARE CANDIDATES FOR ACID SUPPRESSION THERAPY (P&S Industry Clinical Trial)

Nov 16 2017 - Nov 16 2022

Selected Publications

Picoraro JA1, Lee D1, Heller CA, Weaver A, Hyams JS, Conklin LS, Otley A, Ziring D, Kugathasan S, Rosh JR, Mulberg A, Denson LA, Kappelman M, Grossman A, Bousvaros A, Park KT. Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn’s & Colitis Foundation: Charting the Future of Pediatric IBD. Inflamm Bowel Dis. 2019 Jan 1;25(1):27-32.

Gluchowski NL, Chitraju C, Picoraro JA, Mejhert N, Pinto S, Xin W, Kamin DS, Winter HS, Chung WK, Walther TC, Farese RV Jr.Identification and Characterization of a Novel DGAT1 Missense Mutation Associated with Congenital Diarrhea. J Lipid Res.2017 Jun;58(6):1230-1237.

Picoraro J, Winberry G, Siegel CA, El-Matary W, Moses J, Grossman A, Park KT. Premedication Use Before Infliximab Administration: A Cross-sectional Analysis. Inflamm Bowel Dis. 2017 Jan;23(1):174-180.

Picoraro JA, Pierog A, Reilly NR, Mencin AA. Gastrojejunal Tube Placement Through an Established Gastrostomy via an Endoscopic Transgastric Approach in a Pediatric Population. Gastrointest Endosc. 2015 Dec;82(6):1025-30.